Статус неизвестен
Фаза I–II
CD4+CD25+CD127lowFoxP3+ T regulatory cells injection; Alemtuzumab; Mycophenolate mofetil; Sirolimus; Tacrolimus; Cyclosporine; Everolimus · Pirogov Russian National Research Medical University
Phase 1 Pilot Study Using Autologous CD4+CD25+FoxP3+ T Regulatory Cells and Campath-1H to Induce Renal Transplant Tolerance